相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。p53 expression in large B-cell lymphomas with MYC extra copies and CD99 expression in large B-cell lymphomas in relation to MYC status
Aida Ibricevic Richardson et al.
HUMAN PATHOLOGY (2019)
Double hit and double expressors in lymphoma: Definition and treatment
Peter A. Riedell et al.
CANCER (2018)
Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements
Pierre Sesques et al.
BLOOD (2017)
Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma
Andres E. Quesada et al.
MODERN PATHOLOGY (2017)
High grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6: Double hit and triple hit lymphomas and double expressing lymphoma
Allison Rosenthal et al.
BLOOD REVIEWS (2017)
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma
Daniel J. Landsburg et al.
CANCER (2016)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable
Daniel J. Landsburg et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
MYC Cytogenetic Status Correlates With Expression and Has Prognostic Significance in Patients With MYC/BCL2 Protein Double-positive Diffuse Large B-cell Lymphoma
Xuan Julia Wang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis
Christina Howlett et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
The Genetic Landscape of Diffuse Large B-Cell Lymphoma
Laura Pasqualucci et al.
SEMINARS IN HEMATOLOGY (2015)
B-cell lymphomas with concurrent MYC and BCL2 abnormalities other than translocations behave similarly to MYC/BCL2 double-hit lymphomas
Shaoying Li et al.
MODERN PATHOLOGY (2015)
Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis
Adam M. Petrich et al.
BLOOD (2014)
Double hit lymphoma: the MD Anderson Cancer Center clinical experience
Yasuhiro Oki et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma
Shaoying Li et al.
ADVANCES IN ANATOMIC PATHOLOGY (2013)
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
Heike Horn et al.
BLOOD (2013)
Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Tina Marie Green et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Nathalie A. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
Bertrand Coiffier et al.
BLOOD (2010)
MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy
Kerry J. Savage et al.
BLOOD (2009)
MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type
S. O. Yoon et al.
HISTOPATHOLOGY (2008)
MYC - TIMELINE Reflecting on 25 years with MYC
Natalie Meyer et al.
NATURE REVIEWS CANCER (2008)
Non-Hodgkin's lymphomas with Burkitt-like cells are associated with c-Myc amplification and poor prognosis
H. Mossafa et al.
LEUKEMIA & LYMPHOMA (2006)
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
CP Hans et al.
BLOOD (2004)